Hydrophilic and hydrophobic cyclodextrins in a new sustained release oral formulation of nicardipine: In vitro evaluation and bioavailability studies in rabbits

Journal of Controlled Release

Volumn 88, Issue 1, 2003, Pages 127-134

  Marques Fernandes, Catarina ^a   Ramos, Pedro ^b   Celta Falcão, Amílcar ^a   Baptista Veiga, Francisco José ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Drug sustained release; Hydrophilic CDs; Hydrophobic CDs; Nicardipine

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN; CYCLODEXTRIN; NICARDIPINE; TRIACETYL BETA CYCLODEXTRIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; FEASIBILITY STUDY; HYDROPHILICITY; HYDROPHOBICITY; NONHUMAN; PRIORITY JOURNAL; RABBIT; RACEMIC MIXTURE; SIMULATION;

EID: 0037436015     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(02)00465-0     Document Type: Article

References (17)

1. Bekers O., Uijtendall E., Beijnen J., Buit A., Underberg W. Cyclodextrins in the pharmaceutical field. Drug Dev. Ind. Pharm. 17:1991;1503-1549.
2. Szejtli J. Cyclodextrins in pharmaceuticals. Szejtli J. Cyclodextrin Technology. 1988;186-306 Kluwer, Dordrecht.
3. Uekema K., Hirayama F., Irie T. Cyclodextrin drug carrier system. Chem. Rev. 98:1998;2045-2076.
4. Badawy S.I.F., Marshall A.L., Ghorab M.M., Adeyeye C.M. A study of the complexation between danazol and hydrophilic cyclodextrin derivatives. Drug Dev. Ind. Pharm. 22:1996;959-966.
5. Dollo G., Corre P., Chollet M., Chevanne F., Bertault M., Burgot J., Verge R. Improvement in solubility and dissolution rate of 1,2-dithiole-3-thiones upon complexation with β-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives. J. Pharm. Sci. 88:1999;889-895.
6. Moyano J.R., Gines J.M., Arias M.J., Rabasco A.M. Evaluation of dissolution characteristics of oxazepam-2-hydroxypropyl-β-cyclodextrin binary systems. Pharm. Acta Helv. 69:1994;81-90.
7. Hirayama F., Yamasaka M., Horikawa T., Uekama K. Characterization of peracylated β-cyclodextrins with different chain lengths as a novel sustained release carrier for water-soluble drugs. Chem. Pharm. Bull. 43:1995;130-136.
8. Lemesle-Lamache V., Wouessidjewe D., Chéron M., Duchêne D. Study of β-cyclodextrin and ethylated β-cyclodextrin salbutamol complexes, in vitro evaluation of sustained-release behaviour of salbutamol. Int. J. Pharm. 141:1996;117-124.
9. Ikeda Y., Kimura K., Hirayama F., Arima H., Uekama K. Controlled release of a water-soluble drug, captopril, by a combination of hydrophilic and hydrophobic cyclodextrin derivatives. J. Controlled Release. 66:2000;271-280.
10. Fernandes C.M., Vieira M.T., Veiga F.J.B. Physicochemical characterization and in vitro dissolution behaviour of nicardipine-cyclodextrins inclusion compounds. Eur. J. Pharm. Sci. 15:2002;79-88.
11. Fernandes C.M., Veiga F.J.B. Effect of the hydrophobic nature of triacetyl-β-cyclodextrin on the complexation with nicardipine: physicochemical and dissolution properties of the kneaded and spray-dried complexes. Chem. Pharm. Bull. 50:2002;1597-1602.
12. Sorkin E., Clissold S. Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders. Drugs. 33:1987;296-345.
13. Özyazici M., Sevgi F., Ertan G. Sustained-release dosage form of nicardipine hydrochloride: application of factorial design and effect of surfactant on release kinetics. Drug Dev. Ind. Pharm. 23:1997;761-770.
14. Yüksel N., Dinç E., Onur F., Baykara T. Influence of swelling degree on release of nicardipine hydrochloride from acrylic microspheres prepared by solvent evaporation method. Pharm. Dev. Technol. 3:1998;115-121.
15. C.M. Fernandes, F.J.B. Veiga, A simple method for nicardipine quantification in plasma using solid-phase extraction and reversed high-performance liquid chromatography, Biomed. Chromatogr., in press.
16. Lin S., Kao Y. Solid particulates of drug-β-cyclodextrin inclusion complexes directly prepared by a spray-drying technique. Int. J. Pharm. 56:1989;249-259.
17. Moyano J.R., Arias-Blanco M.J., Gines J.M., Giordano F. Solid-state characterization and solid dissolution characteristics of glycazide-β-cyclodextrin inclusion complexes. Int. J. Pharm. 148:1997;211-217.